Alkion BioInnovations Email Format
Biotechnology ResearchÎle-de-france, France11-50 Employees
Alkion BioInnovations is a biotechnology research company based near Versailles in the Île-de-France region, focused on plant tissue propagation and bioengineering. It has developed a bioproduction platform that yields high-value ingredients—from active pharmaceutical ingredients to recombinant proteins—from plant biomass for pharmaceutical and agrifood markets. The production approach emphasizes sustainability and scalability, leveraging carbon-neutral methods and optimized bioreactors to minimize resource use. In Europe, the company collaborates with partners to advance AI-powered robotics for an industrial in-vitro bioproduction platform. Its main initiative is the large-scale production of QS, derived from the Quillaja saponaria tree, intended to boost vaccine efficacy and expand access while preserving biodiversity; the program involves collaboration with NGOs and universities. A secondary program focuses on standardized cannabinoid APIs and extracts for therapeutic markets, supported by a French health authorities R&D license granted in 2018, alongside an agrifood biosynthesis effort for a healthy sweet protein from an exotic plant.